Daniel Clark
Stock Analyst at Leerink Partners
(1.28)
# 3,333
Out of 4,829 analysts
3
Total ratings
50%
Success rate
-0.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Initiates: Market Perform | $14 | $11.96 | +17.06% | 1 | Dec 2, 2024 | |
| IDXX IDEXX Laboratories | Initiates: Outperform | $500 | $491.70 | +1.69% | 1 | Dec 2, 2024 | |
| ZTS Zoetis | Initiates: Outperform | $215 | $159.27 | +34.99% | 1 | Dec 2, 2024 |
Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $11.96
Upside: +17.06%
IDEXX Laboratories
Dec 2, 2024
Initiates: Outperform
Price Target: $500
Current: $491.70
Upside: +1.69%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $159.27
Upside: +34.99%